Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$1.69B |
| 2 |
SPYM
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$1.32B |
| 3 |
Vanguard Total Bond Market
BND
|
+$1.21B |
| 4 |
SPDR Gold Trust
GLD
|
+$970M |
| 5 |
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
|
+$842M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$7.66B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$5.23B |
| 3 |
Accenture
ACN
|
+$1.14B |
| 4 |
Advanced Micro Devices
AMD
|
+$1.13B |
| 5 |
Vanguard Short-Term Bond ETF
BSV
|
+$635M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.44% |
| 2 | Financials | 11.14% |
| 3 | Consumer Discretionary | 8.06% |
| 4 | Healthcare | 8.02% |
| 5 | Communication Services | 7.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1351
Nuveen AMT-Free Quality Municipal Income Fund
NEA
$3.41B
| $113M | 0.01% |
9,700,112
-472,974
| -5% | -$5.44M |
|
1352
Sprott Physical Silver Trust
PSLV
$13.7B
| $113M | 0.01% |
4,760,761
+353,293
| +8% | +$6.47M |
|
1353
Stoke Therapeutics
STOK
$2.08B
| $113M | 0.01% |
3,546,158
+9,108
| +0.3% | +$274K |
|
1354
Ambev
ABEV
$45.4B
| $112M | 0.01% |
45,462,628
+33,842,540
| +291% | +$80.6M |
|
1355
Eaton Vance Ultra-Short Income ETF
EVSB
$244M
| $112M | 0.01% |
2,204,667
+419,149
| +23% | +$21.4M |
|
1356
Vodafone
VOD
$36.4B
| $112M | 0.01% |
8,487,605
-1,544,540
| -15% | -$18.7M |
|
1357
WisdomTree Emerging Markets ex-State-Owned Enterprises Fund
XSOE
$2.07B
| $112M | 0.01% |
2,870,785
+126,730
| +5% | +$4.9M |
|
1358
Robert Half
RHI
$4.37B
| $112M | 0.01% |
4,121,421
-677,879
| -14% | -$19.3M |
|
1359
Alcon
ALC
$35.9B
| $112M | 0.01% |
1,419,370
-765,370
| -35% | -$58.9M |
|
1360
Avantis US Equity ETF
AVUS
$14.3B
| $111M | 0.01% |
994,121
-76,999
| -7% | -$8.48M |
|
1361
iShares MSCI United Kingdom ETF
EWU
$4.15B
| $111M | 0.01% |
2,523,562
+253,162
| +11% | +$10.8M |
|
1362
Pacer Developed Markets International Cash Cows 100 ETF
ICOW
$1.85B
| $111M | 0.01% |
2,868,753
+104,275
| +4% | +$3.97M |
|
1363
TeraWulf
WULF
$8.08B
| $111M | 0.01% |
9,641,209
+724,286
| +8% | +$9.71M |
|
1364
Chemed
CHE
$7.18B
| $111M | 0.01% |
258,833
-90,428
| -26% | -$39.4M |
|
1365
Victory Portfolios II VictoryShares Short-Term Bond ETF
USTB
$2.4B
| $111M | 0.01% |
2,173,526
+486,138
| +29% | +$24.7M |
|
1366
KBR
KBR
$4.83B
| $110M | 0.01% |
2,748,597
+2,128,895
| +344% | +$91.3M |
|
1367
Omega Healthcare
OHI
$14.4B
| $110M | 0.01% |
2,490,333
-454,663
| -15% | -$19.6M |
|
1368
PJT Partners
PJT
$4.33B
| $110M | 0.01% |
659,729
+45,758
| +7% | +$7.83M |
|
1369
Atmus Filtration Technologies
ATMU
$4.05B
| $110M | 0.01% |
2,123,403
-193,416
| -8% | -$9.36M |
|
1370
iShares Global Tech ETF
IXN
$9.17B
| $110M | 0.01% |
1,049,090
-3,151
| -0.3% | -$333K |
|
1371
Acushnet Holdings
GOLF
$5.34B
| $110M | 0.01% |
1,379,236
+251,889
| +22% | +$20.4M |
|
1372
Cemex
CX
$16.3B
| $110M | 0.01% |
9,579,658
+1,916,729
| +25% | +$19.8M |
|
1373
Telus
TU
$15.1B
| $110M | 0.01% |
8,347,951
-511,172
| -6% | -$7.2M |
|
1374
Mitsubishi UFJ Financial
MUFG
$251B
| $110M | 0.01% |
6,904,972
-77,692
| -1% | -$1.2M |
|
1375
KT
KT
$8.72B
| $109M | 0.01% |
5,767,963
-720,244
| -11% | -$13.4M |
|
Similar funds
Morgan Stanley's Q4 2025 Portfolio in Review
As of Q4 2025, Morgan Stanley held 8,587 positions worth $1.67T, up 1.4% from $1.65T the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Morgan Stanley's Q4 2025 filing shows 427 new, 3,946 increased, 2,962 reduced and 384 closed positions. Its largest new stake was Medline Inc: 15,162,060 shares worth $637M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $7.66B.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Financials and Consumer Discretionary.
- Morgan Stanley's largest Q4 2025 buy was Medline Inc: 15,162,060 shares worth $637M.
- Morgan Stanley added most to Vanguard FTSE Developed Markets ETF in Q4 2025, an estimated $1.69B increase.
- Morgan Stanley's biggest Q4 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $7.66B.
- Morgan Stanley fully exited Mr. Cooper in Q4 2025, selling an estimated $312M.
- Morgan Stanley's ten largest holdings make up 22% of its $1.67T portfolio in Q4 2025.
- Morgan Stanley opened 427 new positions and closed 384 in Q4 2025.
- Morgan Stanley's portfolio value rose 1.4% quarter-over-quarter to $1.67T.
Based on Morgan Stanley's 13F filing for Q4 2025, filed 13 Feb 2026.